Genetic Testing & Targeted Therapy (for Prostate Cancer) | Leanne Burnham, PhD | The Patient Story

Dr. Leanne Burnham knows all too well how little the general public understands about prostate cancer,especially when it comes to newer trends and information like the importance of genomic testing and the fast pace of targeted therapy development. In this segment, Dr. Burnham talks about the latest in developments, including what her colleagues at City of Hope, are working on. In this Series: Our 4-part series with Leanne Burnham, PhD, an assistant research professor at City of Hope near Los Angeles, describes how passionate she is in her work to help men, especially those of color, avoid and deal with prostate cancer. Her reason for doing this could not be more personal: her own father, Theo, was diagnosed with advanced prostate cancer. It’s a case she said should have never happened, had medical care providers known to watch his case differently as a Black man with different cancer patterns. Full story & transcript → https://www.thepatientstory.com/medic... The interview has only been edited for clarity. Join Our Community: Website : https://www.thepatientstory.com/ Facebook: @ThePatientStory Instagram: @ThePatientStory Twitter: @patient_story ______________________________ Contents of this video: 00:00 - Intro 00:23 - Importance of Genomic Testing 02:20 - What should people understand about clinical trials? 05:47 - PARP Inhibitor Study on Prostate Cancer 07:13 - Getting heavy into the Science 10:46 - How to get more Diversity in Clinical Trials 15:55 - The Importance of Telehealth & Telemedicine 21:24 - What is preventing some men in communities from screening 23:33 - What does success look like to you in your prostate cancer work? ______________________________ #ThePatientStory #Prostatecancer #CancerSurvivor #cancerawareness #prostatecancerawareness